Ingevity Corporation $NGVT Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System decreased its holdings in shares of Ingevity Corporation (NYSE:NGVTFree Report) by 21.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,338 shares of the company’s stock after selling 11,864 shares during the period. New York State Teachers Retirement System’s holdings in Ingevity were worth $3,087,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in NGVT. Global Retirement Partners LLC purchased a new stake in Ingevity in the 4th quarter worth $27,000. Meeder Asset Management Inc. purchased a new position in Ingevity during the fourth quarter valued at $33,000. Geneos Wealth Management Inc. lifted its holdings in Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after purchasing an additional 387 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of Ingevity in the second quarter valued at about $46,000. Finally, Kestra Advisory Services LLC purchased a new stake in shares of Ingevity during the fourth quarter worth about $47,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Stock Performance

Shares of Ingevity stock opened at $72.14 on Friday. The business’s 50 day moving average price is $71.00 and its 200 day moving average price is $69.59. The company has a market cap of $2.51 billion, a price-to-earnings ratio of -20.32 and a beta of 1.16. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. Ingevity Corporation has a one year low of $39.74 and a one year high of $79.29.

Ingevity (NYSE:NGVTGet Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. During the same period in the prior year, the business earned $1.01 EPS. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, research analysts predict that Ingevity Corporation will post 5.05 EPS for the current year.

Analyst Upgrades and Downgrades

NGVT has been the topic of a number of research reports. Wall Street Zen raised shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Ingevity has a consensus rating of “Hold” and an average target price of $80.00.

Check Out Our Latest Stock Report on Ingevity

Insider Buying and Selling at Ingevity

In related news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.88% of the company’s stock.

About Ingevity

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Featured Stories

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVTFree Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.